Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT07095608

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain

Led by New York University · Updated on 2025-11-21

80

Participants Needed

1

Research Sites

225 weeks

Total Duration

On this page

Sponsors

N

New York University

Lead Sponsor

N

National Institute of Dental and Craniofacial Research (NIDCR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a prospective study involving human participants. Pressure and stretch sensitivity measures between oral cancer patients and healthy subjects will be compared. Pain stimulation will be conducted on the site of the cancer in 40 oral cancer patients, and on the tongue in 40 healthy volunteers, using pressure and stretch sensitivity tests.

CONDITIONS

Official Title

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

For healthy subjects to be eligible to participate in this study, an individual must meet all of the following criteria:

  • Provide signed and dated informed consent form
  • Willing to comply with all study procedures and be available for the duration of the study
  • Male or female, at least 18 years of age
  • In good general health as evidenced by medical history

For oral cancer patients to be eligible to participate in this study, an individual must meet all of the following criteria:

  • Provide signed and dated informed consent form
  • Willing to comply with all study procedures and be available for the duration of the study
  • Male or female, at least 18 years of age
  • Biopsy-proven squamous cell carcinoma (SCC) of the oral cavity that requires surgical resection
  • Lesion is at least 1 cm in greatest surface dimension
Not Eligible

You will not qualify if you...

  • Healthy subjects who meet any of the following criteria will be excluded from participation in this study:

    • Clinically and/or histologically proven oral pre-cancer, oral cancer
    • Pregnancy or lactation (Female subjects of child-bearing potential will have a rapid urine pregnancy test)
    • Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.

Oral cancer patients who meet any of the following criteria will be excluded from participation in this study:

  • History of prior surgical, chemotherapeutic, or radiation treatment for head and neck cancer
  • Pregnancy or lactation
  • Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.

For participants with impaired kidney function (chronic kidney/renal disease) who wish to participate in the proposed research study, consultation with their primary care provider will be done prior to enrollment to determine safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

NYU College of Dentistry

New York, New York, United States, 10010

Actively Recruiting

Loading map...

Research Team

Y

Yatendra Mulpuri, PhD

CONTACT

M

Mariana Bucovsky, MHA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain | DecenTrialz